Kite Appoints Frank Neumann as Worldwide Head of Clinical Development
Kite Appoints Frank Neumann as Worldwide Head of Clinical Development Industry Leader in Cell Therapy and Oncology Drug Development Positioned for Continued Advancement of Kite’s Clinical Programs — Kite, a Gilead Company today announced that Frank Neumann, MD, PhD, has joined the company as Senior Vice President and Global Head of Clinical Development. Dr. Neumann will lead Kite’s Clinical Development organization across hematological malignancies and solid tumors. Ken … — Industry Leader in Cell Therapy and Oncology Drug Development Positioned for Continued Advancement of Kite’...
Source: investingnews.com